Corrigendum: Inhaled Milrinone after Left Ventricular Assist Device Implantation (Journal of Cardiac Failure (2015) 21:10 (792-797) doi:10.1016/j.cardfail.2015.04.011);Inhaled milrinone after left ventricular assist device implantation

Journal of Cardiac Failure

Volumn 21, Issue 10, 2015, Pages 792-797

  Haglund, Nicholas A ^a   Burdorf, Adam ^a   Jones, Tara ^a   Shostrom, Valerie ^a   Um, John ^a   Ryan, Timothy ^a   Shillcutt, Sasha ^b   Fischer, Patricia ^a   Cox, Zachary L ^c   Raichlin, Eugenia ^a   Lowes, Brian D ^a   Dumitru, Ioana ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c LIPSCOMB UNIVERSITY   (United States)

Author keywords

left ventricular assist device; nebulization; Phosphodiesterase inhibitor; right ventricular dysfunction

Indexed keywords

MILRINONE; NITRIC OXIDE; VASODILATOR AGENT;

ADULT; ARTICLE; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; ECHOCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; FEMALE; HEALTH CARE COST; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; HUMAN; HYPOTENSION; IMPLANTATION; LEFT VENTRICULAR ASSIST DEVICE; LUNG ARTERY PRESSURE; MALE; NEBULIZATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; TREATMENT DURATION; URINARY EXCRETION; AGED; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG EFFECTS; ECONOMICS; HEART ASSIST DEVICE; HEART FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PHASE 1 CLINICAL TRIAL; PHYSIOLOGY; POSTOPERATIVE CARE; PREVENTION AND CONTROL; PROCEDURES; TREATMENT OUTCOME; TRENDS;

ADMINISTRATION, INHALATION; AGED; COST-BENEFIT ANALYSIS; FEMALE; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MILRINONE; POSTOPERATIVE CARE; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84942596074     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2015.12.001     Document Type: Erratum

References (20)

1. J.K. Kirklin, D.C. Naftel, F.D. Pagani, R.L. Kormos, L.W. Stevenson, E.D. Blume, and et al. Sixth INTERMACS annual report: a 10,000-patient database J Heart Lung Transplant 33 2014 555 564
2. R.L. Kormos, J.J. Teuteberg, F.D. Pagani, S.D. Russell, R. John, L.W. Miller, and et al. Right ventricular failure in patients with the Heartmate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes J Thorac Cardiovasc Surg 139 2010 1316 1324
3. L.W. Miller, and K. Lietz Candidate selection for long-term left ventricular assist device therapy for refractory heart failure J Heart Lung Transplant 25 2006 756 764
4. R. John, F.D. Pagani, Y. Naka, A. Boyle, J.V. Conte, S.D. Russell, and et al. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables J Thorac Cardiovasc Surg 140 2010 174 181
5. E. Potapov, D. Meyer, M. Swaminathan, M. Ramsay, A. el Banayosy, C. Diehl, and et al. Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial J Heart Lung Transplant 30 2011 870 878
6. G. Hasenfuss, and J.R. Teerlink Cardiac inotropes: current agents and future directions Eur Heart J 32 2011 1838 1845
7. G.M. Felker, R.L. Benza, A.B. Chandler, J.D. Leimberger, M.S. Cuffe, R.M. Califf, and et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study J Am Coll Cardiol 41 2003 997 1003
8. S.A. Haraldsson, N. Kieler-Jensen, and S.E. Ricksten The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension Anesth Analg 93 2001 1439 1445
9. A. Sablotzki, W. Starzmann, R. Scheubel, S. Grond, and E.G. Czeslick Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates Can J Anaesth 52 2005 1076 1082
10. H. Wang, M. Gong, B. Zhou, and A. Dai Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery Adv Ther 26 2009 462 468
11. R. Singh, M. Choudhury, A. Saxena, P.M. Kapoor, R. Juneja, and U. Kiran Inhaled nitroglycerin versus inhaled milrinone in children with congenital heart disease suffering from pulmonary artery hypertension J Cardiothorac Vasc Anesth 24 2010 797 801
12. M.S. Buckley, and J.P. Feldman Nebulized milrinone use in a pulmonary hypertensive crisis Pharmacotherapy 27 2007 1763 1766
13. J.R. Fitzpatrick 3rd, J.R. Frederick, V.M. Hsu, E.D. Kozin, M.L. O'Hara, E. Howell, and et al. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support J Heart Lung Transplant 27 2008 1286 1292
14. A.Q. Nguyen, Y. Theoret, C. Chen, A. Denault, and F. Varin High performance liquid chromatography using UV detection for the quantification of milrinone in plasma: Improved sensitivity for inhalation J Chromatogr B Analyt Technol Biomed Life Sci 877 2009 657 660
15. Haglund NA, Luethge M, Duryee M, Hunter C, Alnouti Y, Corcoran T, et al. Pre-clinical testing of aerosolized inhaled milrinone using a vibrating mesh nebulizer. J Heart Lung Transplant 2013;32(4):S252-S253.
16. J.C. Matthews, T.M. Koelling, F.D. Pagani, and K.D. Aaronson The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates J Am Coll Cardiol 51 2008 2163 2172
17. B.E. Jaski, M.A. Fifer, R.F. Wright, E. Braunwald, and W.S. Colucci Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. dose-response relationships and comparison to nitroprusside J Clin Invest 75 1985 643 649
18. A. Vazir, N. Leaver, H. Lyster, A. Alexanian, P. Wilton, and N.R. Banner Is monitoring milrinone therapy useful in advanced heart failure? Int J Cardiol 149 2011 380 381
19. D. Charisopoulou, N. Leaver, and N.R. Banner Milrinone in advanced heart failure: Dose and therapeutic monitor outside intensive care unit Angiology 65 2014 343 349
20. Z.L. Cox, M.W. Calcutt, T.B. Morrison, W.S. Akers, M.B. Davis, and D.J. Lenihan Elevation of plasma milrinone concentrations in stage D heart failure associated with renal dysfunction J Cardiovasc Pharmacol Ther 18 2013 433 438